Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 408

1.

Training curriculum for European thoracic surgeons: a joint initiative of the European Society of Thoracic Surgeons and the European Respiratory Society.

Massard G, Tabin N, Konge L, Frick AE, Batirel H, Brunelli A, Elia S, Huertgen M, Molins L, Papagiannopoulos K, Subotic D, van Schil P, Varela G, van Raemdonck D.

Eur Respir J. 2020 Feb 6;55(2). pii: 1902012. doi: 10.1183/13993003.02012-2019. Print 2020 Feb. No abstract available.

PMID:
32029642
2.

Training curriculum for European thoracic surgeons: a joint initiative of the European Society of Thoracic Surgeons and the European Respiratory Society.

Massard G, Tabin N, Konge L, Frick AE, Batirel H, Brunelli A, Elia S, Huertgen M, Molins L, Papagiannopoulos K, Subotic D, van Schil P, Varela G, van Raemdonck D.

Eur J Cardiothorac Surg. 2020 Mar 1;57(3):418-421. doi: 10.1093/ejcts/ezz361.

PMID:
32025700
3.

Ewing's sarcoma of the sternum necessitating complex resection and reconstruction.

Vissers G, Van Houtven L, Corthouts J, Snoeckx A, Luijks M, Thiessen F, Tondu T, Van Schil P.

Case Reports Plast Surg Hand Surg. 2019 Apr 15;6(1):125-130. doi: 10.1080/23320885.2019.1598867. eCollection 2019.

4.

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S.

Ann Oncol. 2019 May;30(5):863-870. doi: 10.1093/annonc/mdy474. Epub 2019 Dec 4. No abstract available.

PMID:
31987360
5.

The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies.

Van Der Steen N, Zwaenepoel K, Mazzaschi G, A Luirink R, P Geerke D, Op de Beeck K, Hermans C, Tiseo M, Van Schil P, Lardon F, Germonpré P, Rolfo C, Giovannetti E, J Peters G, Pauwels P.

Molecules. 2019 Dec 4;24(24). pii: E4443. doi: 10.3390/molecules24244443.

6.

A combined intrapleural administration of dornase alfa and tissue plasminogen activator is safe in children with empyema - A pilot study.

Slaats MA, De Dooy J, Van Hoorenbeeck K, Van Schil PEY, Verhulst SL, Hendriks JMH.

Acta Chir Belg. 2019 Dec 3:1-5. doi: 10.1080/00015458.2019.1696516. [Epub ahead of print]

PMID:
31750793
7.

The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.

Edwards JG, Chansky K, Van Schil P, Nicholson AG, Boubia S, Brambilla E, Donington J, Galateau-Sallé F, Hoffmann H, Infante M, Marino M, Marom EM, Nakajima J, Ostrowski M, Travis WD, Tsao MS, Yatabe Y, Giroux DJ, Shemanski L, Crowley J, Krasnik M, Asamura H, Rami-Porta R; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions.

J Thorac Oncol. 2020 Mar;15(3):344-359. doi: 10.1016/j.jtho.2019.10.019. Epub 2019 Nov 13.

PMID:
31731014
8.

Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy.

Van Meerbeeck JP, De Pooter C, Raskin J, Janssens A, Van Schil PE.

Curr Opin Oncol. 2020 Jan;32(1):54-62. doi: 10.1097/CCO.0000000000000596.

PMID:
31688138
9.

Molecular profiling in lung cancer associated with cystic airspaces.

Snoeckx A, Reyntiens P, Pauwels P, Van Schil PE, Parizel PM, Van Meerbeeck JP.

Acta Clin Belg. 2019 Oct 15:1-4. doi: 10.1080/17843286.2019.1680134. [Epub ahead of print]

PMID:
31615350
10.

154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center randomized controlled double-blind trial.

Van Regenmortel N, Hendrickx S, Roelant E, Baar I, Dams K, Van Vlimmeren K, Embrecht B, Wittock A, Hendriks JM, Lauwers P, Van Schil PE, Van Craenenbroeck AH, Verbrugghe W, Malbrain MLNG, Van den Wyngaert T, Jorens PG.

Intensive Care Med. 2019 Oct;45(10):1422-1432. doi: 10.1007/s00134-019-05772-1. Epub 2019 Oct 1.

11.

EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.

Nicholson AG, Sauter JL, Nowak AK, Kindler HL, Gill RR, Remy-Jardin M, Armato SG 3rd, Fernandez-Cuesta L, Bueno R, Alcala N, Foll M, Pass H, Attanoos R, Baas P, Beasley MB, Brcic L, Butnor KJ, Chirieac LR, Churg A, Courtiol P, Dacic S, De Perrot M, Frauenfelder T, Gibbs A, Hirsch FR, Hiroshima K, Husain A, Klebe S, Lantuejoul S, Moreira A, Opitz I, Perol M, Roden A, Roggli V, Scherpereel A, Tirode F, Tazelaar H, Travis WD, Tsao MS, van Schil P, Vignaud JM, Weynand B, Lang-Lazdunski L, Cree I, Rusch VW, Girard N, Galateau-Salle F.

J Thorac Oncol. 2020 Jan;15(1):29-49. doi: 10.1016/j.jtho.2019.08.2506. Epub 2019 Sep 20.

PMID:
31546041
12.

Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.

Dingemans AC, Hendriks LEL, Berghmans T, Levy A, Hasan B, Faivre-Finn C, Giaj-Levra M, Giaj-Levra N, Girard N, Greillier L, Lantuéjoul S, Edwards J, O'Brien M, Reck M, Smit EF, Van Schil P, Postmus PE, Ramella S, Lievens Y, Gaga M, Peled N, Scagliotti GV, Senan S, Paz-Ares L, Guckenberger M, McDonald F, Ekman S, Cufer T, Gietema H, Infante M, Dziadziuszko R, Peters S, Porta RR, Vansteenkiste J, Dooms C, de Ruysscher D, Besse B, Novello S.

J Thorac Oncol. 2019 Dec;14(12):2109-2119. doi: 10.1016/j.jtho.2019.07.025. Epub 2019 Aug 6.

PMID:
31398540
13.

Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!

Berzenji L, Beckers P, Van Schil PE.

J Thorac Dis. 2019 May;11(Suppl 9):S1153-S1156. doi: 10.21037/jtd.2019.04.36. No abstract available.

14.

Surgery or stereotactic body radiotherapy for early-stage lung cancer: two sides of the same coin?

Berzenji L, Van Schil PE.

Eur Respir J. 2019 Jun 20;53(6). pii: 1900711. doi: 10.1183/13993003.00711-2019. Print 2019 Jun. No abstract available.

PMID:
31221681
15.

Diagnostic and clinical features of lung cancer associated with cystic airspaces.

Snoeckx A, Reyntiens P, Carp L, Spinhoven MJ, El Addouli H, Van Hoyweghen A, Nicolay S, Van Schil PE, Pauwels P, van Meerbeeck JP, Parizel PM.

J Thorac Dis. 2019 Mar;11(3):987-1004. doi: 10.21037/jtd.2019.02.91. Review.

16.

Multicenter Phase II Clinical Trial of Isolated Lung Perfusion in Patients With Lung Metastases.

Beckers PAJ, Versteegh MIM, Van Brakel TJ, Braun J, Van Putte B, Maat APWM, Vergauwen W, Rodrigus I, Den Hengst W, Lardon F, De Bruijn E, Guetens G, De Boeck G, Gielis JF, Lauwers P, Denissen L, Hendriks JMH, Van Schil PE.

Ann Thorac Surg. 2019 Jul;108(1):167-174. doi: 10.1016/j.athoracsur.2019.02.071. Epub 2019 Apr 2.

PMID:
30951699
17.

Intrapericardial cavernous hemangioma: an unusual mediastinal tumor!

Cogen A, Haine SE, Paelinck BP, Van Herck PL, Pauwels P, Van Schil PE.

Acta Cardiol. 2020 Feb;75(1):93-94. doi: 10.1080/00015385.2018.1554736. Epub 2019 Jan 16. No abstract available.

PMID:
30650037
18.

Successful treatment of lung adenocarcinoma with gefitinib based on EGFR gene amplification.

Wang C, Xu F, Shen J, Zhang L, Zhang J, Jin J, Ampollini L, van Schil P, Kimura H, Grossi F, Suda K, Zhang B, Ma D; written on behalf of the AME Lung Cancer Collaborative Group.

J Thorac Dis. 2018 Nov;10(11):E779-E783. doi: 10.21037/jtd.2018.10.55. No abstract available.

19.

The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.

Guckenberger M, Aerts JG, Van Schil P, Weder W.

J Thorac Cardiovasc Surg. 2019 Jan;157(1):358-361. doi: 10.1016/j.jtcvs.2018.09.107. Epub 2018 Oct 12. No abstract available. Erratum in: J Thorac Cardiovasc Surg. 2019 Jun;157(6):2549.

PMID:
30557952
20.

Commentary: Size and margin do matter, but is it the whole story?

Beckers PAJ, Berzenji L, Van Schil PE.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1658-1659. doi: 10.1016/j.jtcvs.2018.11.036. Epub 2018 Nov 23. No abstract available.

PMID:
30554794
21.

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.

Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber RM, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora PM, Samarzija M, Scherpereel A, Schlesser M, Sculier JP, Skrickova J, Sotto-Mayor R, Strand TE, Van Schil P, Blum TG.

BMC Cancer. 2018 Nov 20;18(1):1144. doi: 10.1186/s12885-018-5009-y.

22.

A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205).

Raskin J, Surmont V, Cornelissen R, Baas P, van Schil PEY, van Meerbeeck JP.

Transl Lung Cancer Res. 2018 Oct;7(5):593-598. doi: 10.21037/tlcr.2018.05.07. Review.

23.

Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.

De Bondt C, Psallidas I, Van Schil PEY, van Meerbeeck JP.

Transl Lung Cancer Res. 2018 Oct;7(5):562-573. doi: 10.21037/tlcr.2018.10.02. Review.

24.

Extrapleural pneumonectomy: still indicated?

Domen A, Berzenji L, Hendriks JMH, Yogeswaran SK, Lauwers P, Van Meerbeeck JP, Van Schil PE.

Transl Lung Cancer Res. 2018 Oct;7(5):550-555. doi: 10.21037/tlcr.2018.07.07. Review.

25.

The eighth TNM classification for malignant pleural mesothelioma.

Berzenji L, Van Schil PE, Carp L.

Transl Lung Cancer Res. 2018 Oct;7(5):543-549. doi: 10.21037/tlcr.2018.07.05. Review.

26.

Malignant pleural and peritoneal mesothelioma: clinical update 2018.

Van Schil P, Van Meerbeeck J.

Transl Lung Cancer Res. 2018 Oct;7(5):505-506. doi: 10.21037/tlcr.2018.08.19. No abstract available.

27.

Characterization of the thymus in Lrp4 myasthenia gravis: Four cases.

Koneczny I, Rennspiess D, Marcuse F, Dankerlui N, Abdul Hamid M, Mané-Damas M, Maessen J, Van Schil P, Saxena A, Zisimopoulou P, Lazaridis K, Woodhall M, Karagiorgou K, Tzartos J, Tzartos S, De Baets MH, Molenaar PC, Marx A, Zur Hausen A, Losen M, Martinez-Martinez P.

Autoimmun Rev. 2019 Jan;18(1):50-55. doi: 10.1016/j.autrev.2018.07.011. Epub 2018 Nov 8.

28.

Multimodality treatment of malignant pleural mesothelioma.

Berzenji L, Van Schil P.

F1000Res. 2018 Oct 22;7. pii: F1000 Faculty Rev-1681. doi: 10.12688/f1000research.15796.1. eCollection 2018. Review.

29.

Non-small cell lung cancer transgressing an adjacent fissure: does one T category fit all?

Van Schil PE.

J Thorac Dis. 2018 Sep;10(Suppl 26):S3290-S3291. doi: 10.21037/jtd.2018.08.106. No abstract available.

30.

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe.

Rich AL, Baldwin DR, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen NG, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert AP, Milroy R, Mutti L, Paesmans M, Peake MD, Putora PM, de Ruysscher DKM, Sculier JP, Scherpereel A, Subotic DR, Van Schil P, Blum TG.

Eur Respir J. 2018 Dec 20;52(6). pii: 1800610. doi: 10.1183/13993003.00610-2018. Print 2018 Dec.

PMID:
30361252
31.

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275. No abstract available. Erratum in: Ann Oncol. 2019 May;30(5):863-870.

32.

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.

Ann Oncol. 2018 Oct;29 Suppl 4:iv192-iv237. doi: 10.1093/annonc/mdy275. Epub 2020 Jan 7. Review. No abstract available.

PMID:
32169226
33.

A harmonised European training syllabus for thoracic surgery: report from the ESTS/ERS task force group.

Massard G, Tabin N, Mitchell S, Batirel H, Brunelli A, Elia S, Frick A, Huertgen M, Lerut A, Molins L, Papagiannopoulos K, Subotic D, van Schil P, Varela G, van Raemdonck D.

Eur Respir J. 2018 Jun 14;51(6). pii: 1800370. doi: 10.1183/13993003.00370-2018. Print 2018 Jun. No abstract available.

34.

A harmonized European training syllabus for thoracic surgery: report from the ESTS-ERS task force.

Massard G, Tabin N, Mitchell S, Batirel H, Brunelli A, Elia S, Frick A, Huertgen M, Lerut A, Molins L, Papagiannopoulos K, Subotic D, van Schil P, Varela G, van Raemdonck D.

Eur J Cardiothorac Surg. 2018 Aug 1;54(2):214-220. doi: 10.1093/ejcts/ezy206.

PMID:
29800238
35.

MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): study protocol of a multicenter randomised controlled trial.

Bousema JE, Dijkgraaf MGW, Papen-Botterhuis NE, Schreurs HW, Maessen JG, van der Heijden EH, Steup WH, Braun J, Noyez VJJM, Hoeijmakers F, Beck N, van Dorp M, Claessens NJM, Hiddinga BI, Daniels JMA, Heineman DJ, Zandbergen HR, Verhagen AFTM, van Schil PE, Annema JT, van den Broek FJC; MEDIASTrial study group.

BMC Surg. 2018 May 18;18(1):27. doi: 10.1186/s12893-018-0359-6.

36.

Myasthenia gravis appearing after thymectomy heralding recurrent thymoma.

Beckers PAJ, Mercelis R, Heyman S, Verheuen L, Lauwers P, Hendriks JM, Van Schil PE.

Acta Chir Belg. 2019 Jun;119(3):195-197. doi: 10.1080/00015458.2018.1438556. Epub 2018 May 17.

PMID:
29768973
37.

Pancreaticopleural fistula: a rare cause of pleural empyema.

Vanderbruggen W, Dhooghe V, Bracke B, Hartman V, Roeyen G, Ysebaert D, Van Schil P, Chapelle T.

Acta Chir Belg. 2019 Dec;119(6):396-399. doi: 10.1080/00015458.2018.1470293. Epub 2018 May 2.

PMID:
29716451
38.

The 8th TNM edition for lung cancer: a critical analysis.

Van Schil PE, Rami-Porta R, Asamura H.

Ann Transl Med. 2018 Mar;6(5):87. doi: 10.21037/atm.2017.06.45. Review.

39.

Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017.

Donington JS, Kim YT, Tong B, Moreira AL, Bessich J, Weiss KD, Colson YL, Wigle D, Osarogiagbon RU, Zweig J, Wakelee H, Blasberg J, Daly M, Backhus L, Van Schil P.

J Thorac Oncol. 2018 Jun;13(6):767-778. doi: 10.1016/j.jtho.2018.04.002. Epub 2018 Apr 12. Review.

40.

The IASLC Lung Cancer Staging Project: A Renewed Call to Participation.

Giroux DJ, Van Schil P, Asamura H, Rami-Porta R, Chansky K, Crowley JJ, Rusch VW, Kernstine K; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee.

J Thorac Oncol. 2018 Jun;13(6):801-809. doi: 10.1016/j.jtho.2018.02.012. Epub 2018 Feb 22.

41.

Mesothelioma With a Large Prevascular Lymph Node: N1 Involvement or Something Different?

Berzenji L, Van Schil PE, Snoeckx A, Hertoghs M, Carp L.

Ann Thorac Surg. 2018 May;105(5):e189-e191. doi: 10.1016/j.athoracsur.2017.12.016.

PMID:
29355487
42.

Conservative treatment of a posterior intercostal lung herniation: a case report.

Cogen A, Van Schil P, Schurmans J.

Acta Chir Belg. 2019 Apr;119(2):129-131. doi: 10.1080/00015458.2017.1411553. Epub 2018 Jan 3.

PMID:
29298605
43.

Surgery compared to stereotactic body radiation therapy for early-stage non-small cell lung cancer: better, equivalent or worse?

Van Schil PE.

J Thorac Dis. 2017 Nov;9(11):4230-4232. doi: 10.21037/jtd.2017.10.36. No abstract available.

44.

Wolf in Sheep's Clothing: Primary Lung Cancer Mimicking Benign Entities.

Snoeckx A, Dendooven A, Carp L, Desbuquoit D, Spinhoven MJ, Lauwers P, Van Schil PE, van Meerbeeck JP, Parizel PM.

Lung Cancer. 2017 Oct;112:109-117. doi: 10.1016/j.lungcan.2017.07.037. Epub 2017 Aug 5. Review.

PMID:
29191583
45.

Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults.

Hendrickx S, Van Vlimmeren K, Baar I, Verbrugghe W, Dams K, Van Cromphaut S, Roelant E, Embrecht B, Wittock A, Mertens P, Hendriks JM, Lauwers P, Van Schil PE, Van Craenenbroeck AH, Van den Wyngaert T, Jorens P, Van Regenmortel N.

Anaesthesiol Intensive Ther. 2017;49(5):366-372. doi: 10.5603/AIT.a2017.0070. Epub 2017 Nov 24.

46.

Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology.

Snoeckx A, Reyntiens P, Desbuquoit D, Spinhoven MJ, Van Schil PE, van Meerbeeck JP, Parizel PM.

Insights Imaging. 2018 Feb;9(1):73-86. doi: 10.1007/s13244-017-0581-2. Epub 2017 Nov 15. Review.

47.

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer.

Van Schil PE, Berzenji L, Yogeswaran SK, Hendriks JM, Lauwers P.

Front Oncol. 2017 Oct 26;7:249. doi: 10.3389/fonc.2017.00249. eCollection 2017. Review.

48.

Oligometastatic non-small cell lung cancer: is there a role for locoregional therapy?

Berzenji L, Van Schil PE.

J Thorac Dis. 2017 Jul;9(7):1814-1817. doi: 10.21037/jtd.2017.06.108. No abstract available.

49.

Optimal Treatment of Stage IIIA-N2 Non-Small Cell Lung Cancer: A Neverending Story?

Van Schil PE.

J Thorac Oncol. 2017 Sep;12(9):1338-1340. doi: 10.1016/j.jtho.2017.07.001. No abstract available.

50.

Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia.

Van den Bossche J, Deben C, Op de Beeck K, Deschoolmeester V, Hermans C, De Pauw I, Jacobs J, Van Schil P, Vermorken JB, Pauwels P, Peeters M, Lardon F, Wouters A.

J Cancer. 2017 May 12;8(8):1441-1452. doi: 10.7150/jca.18455. eCollection 2017.

Supplemental Content

Loading ...
Support Center